Article
Current management strategies for multidrug-resistant Gram-negative urinary tract infections, a focus on aminoglycosides monotherapy
2024-10-05
Abstract excerpt
Urinary tract infections (UTI) are common, with increasing rates of multidrug resistant pathogens in some countries. Recent trials suggest efficacy of new beta-lactam beta-lactamase inhibitors compared to carbapenems, piperacillin-tazobactam, or quinolones for UTI; however, these newer drugs, as well as the comparators, should probably be reserved for severe and/or non-urinary infections. Aminoglycosides have broa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c095729c-9708-557c-8905-432d3e354116
- DOI
- 10.1016/j.cmicom.2024.105039
